Baidu
map

Blood:RAP1亚型在血小板生成和止血/血栓形成过程中的作用

2018-08-22 MedSci MedSci原创

RAP GTPases是细胞黏附的重要调控因子,作为信号分子,在血小板/巨核细胞系中大量表达。但是,缺乏主要亚型RAP1B的小鼠表现为部分血小板整合素激活缺陷,但血小板计数正常,提示在血小板中存在一条RAP1非依赖性的调节整合素激活的信号通路,RAP GTPases在巨核细胞生理过程中可有可无。为明确单个RAP亚型对血小板生成和血小板在机械损伤或血管渗漏部位激活的重要性,Lucia Stefani

RAP GTPases是细胞黏附的重要调控因子,作为信号分子,在血小板/巨核细胞系中大量表达。但是,缺乏主要亚型RAP1B的小鼠表现为部分血小板整合素激活缺陷,但血小板计数正常,提示在血小板中存在一条RAP1非依赖性的调节整合素激活的信号通路,RAP GTPases在巨核细胞生理过程中可有可无。

为明确单个RAP亚型对血小板生成和血小板在机械损伤或血管渗漏部位激活的重要性,Lucia Stefanini等人条件性敲除巨核细胞系的Rap1a和(或)Rap1b(mKO)。RAP1a/b-mKO小鼠的大血小板明显减少,主要是由于巨核细胞生成血小板受损。在血小板中,两种RAP亚型的功能既有重复又各自具有特异性。仅敲除RAP1B可显著减少α颗粒分泌和细胞骨架RAC1的激活。两种亚型均可明显促进血栓素A2的产生和血小板整合素的内外激活。

同时敲除RAP1A和RAP1B可明显降低血小板聚集、扩散和血凝块收缩。与此一致,Rap1a/b-mKO小鼠生理流动条件的的血栓形成被破坏,但Rap1a-mKO或Rap1b-mKO小鼠的则无类似情况。Rap1a/b-mKO小鼠在实验性血栓形成中具有很强的保护作用,在机械损伤后表现出严重的止血缺陷。此外,Rap1a/b-mKO血小板在发育和炎症部位出血期间阻止血-淋巴混合的能力与对照组没有差别。

总而言之,本研究表明RAP1信号在血小板整合素激活过程中发挥重要作用,并在血小板生成过程中发挥关键作用。血小板RAP1信号对止血/血栓形成至关重要,但在发育和炎症过程中对血管完整性可有可无。


原始出处:

Lucia Stefanini, et al. Functional redundancy between RAP1 isoforms in murine platelet production and function. Blood  2018  :blood-2018-03-838714;  doi: https://doi.org/10.1182/blood-2018-03-838714

本文系梅斯医学(MedSci)原创编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1793046, encodeId=0c541e9304614, content=<a href='/topic/show?id=f821151215d' target=_blank style='color:#2F92EE;'>#RAP1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15121, encryptionId=f821151215d, topicName=RAP1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Mon Oct 01 12:28:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340993, encodeId=8e1a340993d8, content=842156261, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq08fBE4ne4yAYXulsHUXiafWXWEQ1kDkMHtT9loagc1nibPCrwjpESVuPO4De8QTeajAic31lDPfjuA/132, createdBy=92ce1931739, createdName=荒郊野树, createdTime=Sun Aug 26 22:29:12 CST 2018, time=2018-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263056, encodeId=e81712630561f, content=<a href='/topic/show?id=ebb5631e076' target=_blank style='color:#2F92EE;'>#止血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63170, encryptionId=ebb5631e076, topicName=止血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Fri Aug 24 12:28:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340226, encodeId=f27e34022663, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Wed Aug 22 22:54:07 CST 2018, time=2018-08-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1793046, encodeId=0c541e9304614, content=<a href='/topic/show?id=f821151215d' target=_blank style='color:#2F92EE;'>#RAP1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15121, encryptionId=f821151215d, topicName=RAP1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Mon Oct 01 12:28:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340993, encodeId=8e1a340993d8, content=842156261, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq08fBE4ne4yAYXulsHUXiafWXWEQ1kDkMHtT9loagc1nibPCrwjpESVuPO4De8QTeajAic31lDPfjuA/132, createdBy=92ce1931739, createdName=荒郊野树, createdTime=Sun Aug 26 22:29:12 CST 2018, time=2018-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263056, encodeId=e81712630561f, content=<a href='/topic/show?id=ebb5631e076' target=_blank style='color:#2F92EE;'>#止血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63170, encryptionId=ebb5631e076, topicName=止血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Fri Aug 24 12:28:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340226, encodeId=f27e34022663, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Wed Aug 22 22:54:07 CST 2018, time=2018-08-22, status=1, ipAttribution=)]
    2018-08-26 荒郊野树

    842156261

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1793046, encodeId=0c541e9304614, content=<a href='/topic/show?id=f821151215d' target=_blank style='color:#2F92EE;'>#RAP1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15121, encryptionId=f821151215d, topicName=RAP1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Mon Oct 01 12:28:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340993, encodeId=8e1a340993d8, content=842156261, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq08fBE4ne4yAYXulsHUXiafWXWEQ1kDkMHtT9loagc1nibPCrwjpESVuPO4De8QTeajAic31lDPfjuA/132, createdBy=92ce1931739, createdName=荒郊野树, createdTime=Sun Aug 26 22:29:12 CST 2018, time=2018-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263056, encodeId=e81712630561f, content=<a href='/topic/show?id=ebb5631e076' target=_blank style='color:#2F92EE;'>#止血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63170, encryptionId=ebb5631e076, topicName=止血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Fri Aug 24 12:28:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340226, encodeId=f27e34022663, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Wed Aug 22 22:54:07 CST 2018, time=2018-08-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1793046, encodeId=0c541e9304614, content=<a href='/topic/show?id=f821151215d' target=_blank style='color:#2F92EE;'>#RAP1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15121, encryptionId=f821151215d, topicName=RAP1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca282500032, createdName=1249857fm32暂无昵称, createdTime=Mon Oct 01 12:28:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340993, encodeId=8e1a340993d8, content=842156261, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq08fBE4ne4yAYXulsHUXiafWXWEQ1kDkMHtT9loagc1nibPCrwjpESVuPO4De8QTeajAic31lDPfjuA/132, createdBy=92ce1931739, createdName=荒郊野树, createdTime=Sun Aug 26 22:29:12 CST 2018, time=2018-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263056, encodeId=e81712630561f, content=<a href='/topic/show?id=ebb5631e076' target=_blank style='color:#2F92EE;'>#止血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63170, encryptionId=ebb5631e076, topicName=止血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Fri Aug 24 12:28:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340226, encodeId=f27e34022663, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Wed Aug 22 22:54:07 CST 2018, time=2018-08-22, status=1, ipAttribution=)]
    2018-08-22 1e1b8538m79(暂无匿称)

    不错的文章值得拥有哦

    0

相关资讯

Blood:血小板直接参与抵制疟原虫感染!

中心点:血小板直与疟疾患者血液循环中的疟原虫相互作用并可杀死疟原虫,从而协助控制寄生虫血症。摘要:据悉,血小板可辅助机体的先天免疫反应抵抗炎症,虽然目前缺乏该功能在包括疟疾在内的任何人类疾病中的直接证据。近日,Blood杂志上发表一篇文章,Steven Kho等人采用显微镜和流氏细胞术对各种疟原虫(恶性疟原虫、P.vivax、三日疟原虫或诺氏疟原虫)感染的患者的血小板-红细胞之间的相互作用进行探究

Crit Care:血小板储存时间与临床和输血结局的关系

由此可见,PLT储存时间似乎与危重病人或血液病患者的临床结局无关,包括出血、败血症或死亡。最新鲜的PLT(不到3天)与更好的CCI相关,尽管对出血事件没有影响。然而,没有证据可以得出明确的结论,特别是在危重病人中。

JAHA:OSA对接受双重抗血小板治疗的ACS患者血小板功能特征的影响

由此可见,在接受双重抗血小板治疗的ACS患者中,OSA与血小板体积指数水平升高、氯吡格雷诱导的抗血小板效应降低以及高残留血小板反应性的较高发生率相关。

Blood:AMPK-ACC信号通路可调节血小板磷脂含量、增强血小板功能、促进血栓形成

中心点:在血小板中,AMPK-ACC信号通路是调节原发性止血和动脉血栓形成的关键机制。AMPK-ACC信号可通过调节血小板磷脂含量来调控胶原蛋白诱导的花生四烯酸(TXA2)合成、致密颗粒释放。摘要:在凝血酶或胶原蛋白的刺激下,血小板中的AMP-活化蛋白激酶(AMPK)α1被激活,发生磷酸化,进而抑制乙酰CoA羧化酶(ACC)。鉴于ACC对于脂肪酸合成至关重要,而脂肪酸对血小板激活又必不可少,因此,

日本拟开展人造血小板治疗贫血临床研究

日本京都大学计划利用由诱导多能干细胞(iPS细胞)制成的血小板,开展一项治疗再生障碍性贫血的临床研究,相关申请已提请日本政府审批。

NEJM:妊娠期间血小板计数

由此可见,从妊娠早期开始,所有女性在妊娠期间平均血小板计数均下降。对于血小板计数低于100000/每立方毫米的女性,应考虑除妊娠或其并发症以外的其他原因。

Baidu
map
Baidu
map
Baidu
map